THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) trials appear
Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New enzyme replacement shows promise for rare blood clot disorder
Disease control Not yet recruitingThis study looks back at medical records of 94 people with a rare inherited blood disorder called cTTP, which causes dangerous blood clots. Participants received a manufactured version of the missing enzyme (rADAMTS13) through an early access program. Researchers want to see if t…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
New study tracks Real-World safety of adzynma for rare blood clotting disorder
Knowledge-focused Not yet recruitingThis study looks at the safety of a drug called Adzynma in people with a rare inherited blood disorder (congenital TTP). The main goals are to see how many patients develop allergic reactions or antibodies that stop the drug from working. Researchers will review medical records f…
Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC